arrow
S

Sigan L. Hartley

university of wisconsin
H指数:42
被引数:6,865
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Memory and Plasma pTau217 Refine Prognosis in Down Syndrome

记忆和血浆pTau217在唐氏综合征中细化预后

2026-10-020
OAAI
Common data element (CDE) and AI-Enabled approaches for clinical data Management: Workshop proceedings from the NIH INCLUDE Project

临床数据管理中的通用数据元素(CDE)和人工智能赋能方法:NIH INCLUDE项目工作坊会议纪要

2026-08-010
PRE
Imaging and plasma biomarkers for pathological accumulation in Down syndrome

Down综合征中病理积聚的成像和血浆生物标志物

Brain
IF11.7
2025-11-050
PRE
Cross-Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's Disease

横断面FDG在唐氏综合征和常染色体显性阿尔茨海默病中的应用

2025-09-220
PRE
Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's disease

体力活动作为唐氏综合征阿尔茨海默病中的抵抗或韧性机制

2025-06-270
OAAI
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study

使用血浆生物标志物预测唐氏综合征患者中淀粉样蛋白和tau蛋白脑沉积及认知衰退:一项纵向队列研究

2025-06-180
OA
Resistance and resilience to Alzheimer's disease in Down syndrome

唐氏综合征中对抗阿尔茨海默病的抵抗力和恢复力

2025-04-280
OAAI
The striatum is an early, accurate indicator of amyloid burden using [11C]PiB in Down syndrome: Comparison of two radiotracers

纹状体是使用[11C]PiB检测唐氏综合征中淀粉样蛋白负荷的早期、准确指标:两种放射性示踪剂的比较

2025-04-060
OAAI
The effects of mosaicism on biological and clinical markers of Alzheimer's disease in adults with Down syndrome

嵌合体对唐氏综合征成人阿尔茨海默病生物学和临床标志物的影响

2024-12-010
OAAI
Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome

唐氏综合征早期阿尔茨海默病的认知和功能表现及血浆生物标志物

2024-04-142
OAAI